1887

Abstract

A case of native valve endocarditis caused by in a patient with transposition of the great vessels is reported. The patient was treated initially with gentamicin and ceftriaxone; after isolation of enterococci, ceftriaxone was switched to ampicillin. The only virulence factors established in the strain were haemolytic activity and biofilm formation.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.05382-0
2004-03-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/53/3/JM530314.html?itemId=/content/journal/jmm/10.1099/jmm.0.05382-0&mimeType=html&fmt=ahah

References

  1. Connelly, M. S., Liu, P. P., Williams, W. G., Webb, G. D., Robertson, P. & McLaughlin, P. R. ( 1996;). Congenitally corrected transposition of the great arteries in the adult: functional status and complications. J Am Coll Cardiol 27, 1238–1243.[CrossRef]
    [Google Scholar]
  2. Coque, T. M., Patterson, J. E., Steckelberg, J. M. & Murray, B. E. ( 1995;). Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J Infect Dis 171, 1223–1229.[CrossRef]
    [Google Scholar]
  3. Donlan, R. M. & Costerton, J. W. ( 2002;). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15, 167–193.[CrossRef]
    [Google Scholar]
  4. Elsner, H.-A., Sobottka, I., Mack, D., Claussen, M., Laufs, R. & Wirth, R. ( 2000;). Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur J Clin Microbiol Infect Dis 19, 39–42.[CrossRef]
    [Google Scholar]
  5. Facklam, R. R. & Collins, M. D. ( 1989;). Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27, 731–734.
    [Google Scholar]
  6. Fuchs, P. C., Barry, A. L. & Brown, S. D. ( 1996;). Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance.AST Surveillance Group. Diagn Microbiol Infect Dis 24, 213–219.[CrossRef]
    [Google Scholar]
  7. Johnson, A. P., Warner, M., Woodford, N., Speller, D. C. E. & Livermore, D. M. ( 1998;). Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory. BMJ 317, 629–630.[CrossRef]
    [Google Scholar]
  8. Knudtson, L. M. & Hartman, P. A. ( 1992;). Routine procedures for isolation and identification of enterococci and fecal streptococci. Appl Environ Microbiol 58, 3027–3031.
    [Google Scholar]
  9. Le, T. & Bayer, A. S. ( 2003;). Combination antibiotic therapy for infective endocarditis. Clin Infect Dis 36, 615–621.[CrossRef]
    [Google Scholar]
  10. Mylonakis, E. & Calderwood, S. B. ( 2001;). Infective endocarditis in adults. N Engl J Med 345, 1318–1330.[CrossRef]
    [Google Scholar]
  11. National Committee for Clinical Laboratory Standards ( 2002;). Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement. NCCLS document M100-S12. Wayne, PA: NCCLS.
  12. Olaison, L. & Schadewitz, K. ( 2002;). Enterococcal endocarditis in Sweden, 1995–1999: can shorter therapy with aminoglycosides be used? Clin Infect Dis 34, 159–166.[CrossRef]
    [Google Scholar]
  13. Padilla, C., Brevis, P., Lobos, O., Hubert, E. & Zamorano, A. ( 2001;). Production of antimicrobial substances, by hospital bacteria, active against other micro-organisms. J Hosp Infect 49, 43–47.[CrossRef]
    [Google Scholar]
  14. Stepanović, S., Vuković, D., Trajković, V., Samardžić, T., Ćupić, M. & Švabić-Vlahović, M. ( 2001;). Possible virulence factors of Staphylococcus sciuri. FEMS Microbiol Lett 199, 47–53.[CrossRef]
    [Google Scholar]
  15. Tripodi, M. F., Locatelli, A., Adinolfi, L. E., Andreana, A. & Utili, R. ( 1998;). Successful treatment with ampicillin and fluoroquinolones of human endocarditis due to high-level gentamicin-resistant enterococci. Eur J Clin Microbiol Infect Dis 17, 734–736.[CrossRef]
    [Google Scholar]
  16. Vergis, E. N., Shankar, N., Chow, J. W., Hayden, M. K., Snydman, D. R., Zervos, M. J., Linden, P. K., Wagener, M. M. & Muder, R. R. ( 2002;). Association between the presence of enterococcal virulence factors gelatinase, hemolysin, and enterococcal surface protein and mortality among patients with bacteremia due to Enterococcus faecalis. Clin Infect Dis 35, 570–575.[CrossRef]
    [Google Scholar]
  17. Working Party of the British Society for Antimicrobial Chemotherapy ( 1998;). Antibiotic treatment of streptococcal, enterococcal, and staphylococcal endocarditis. Heart 79, 207–210.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.05382-0
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error